De­cen­tral­ized tri­als start­up Cure­base scraps clin­i­cal op­er­a­tions busi­ness unit, nar­rows in on soft­ware plat­form

De­cen­tral­ized clin­i­cal tri­als start­up Cure­base has laid off many em­ploy­ees as the com­pa­ny scraps its clin­i­cal op­er­a­tions busi­ness to fo­cus on soft­ware, per a Thurs­day LinkedIn post from founder and CEO Tom Lem­berg.

Cure­base’s down­siz­ing and nar­rowed am­bi­tions come as the de­cen­tral­ized and hy­brid clin­i­cal tri­als space ad­justs to the re­open­ing of in-per­son tri­als and grow­ing pains fol­low­ing a rapid rise in sim­i­lar star­tups dur­ing the Covid-19 pan­dem­ic. Like oth­er vir­tu­al tri­al providers, Cure­base aimed to im­prove pa­tient en­gage­ment, part­ner with more physi­cians in the com­mu­ni­ty set­ting and en­hance tri­al di­ver­si­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER